In vitro, Lf-ASX-LPs reduced cell loss by 20.1% and oxygen species by 30.0%, ameliorated the reduction in mitochondrial membrane potential under 1-methyl-4-phenylpyridinium-induced toxicity by 40.1%, and reduced extracellular nitric oxide levels under lipopolysaccharide-induced toxicity by 32.0%, indicating cytoprotective and antioxidant effects
[1][2][3][4][5][6][7] Muscle, Tendon, Ligament and Bone Repair By inducing angiogenic growth factor healing, BPC-157 has a broad range of healing properties
Other vascular-modulating platforms combine low-intensity vascular regulation with cytotoxic therapy, radiotherapy, photodynamic therapy or immunotherapy [17, 68, 69]
Product comes with syringes
The innovative blend also includes a fragment of the healing and anti-inflammatory peptide thymosin beta-4 (TB4) , otherwise known as TB-500